Search

Your search keyword '"van Gassen, Koen L.I."' showing total 99 results

Search Constraints

Start Over You searched for: Author "van Gassen, Koen L.I." Remove constraint Author: "van Gassen, Koen L.I." Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
99 results on '"van Gassen, Koen L.I."'

Search Results

1. Large-scale genomic investigation of pediatric cholestasis reveals a novel hepatorenal ciliopathy caused by PSKH1 mutations

2. Comprehensive EHMT1 variants analysis broadens genotype-phenotype associations and molecular mechanisms in Kleefstra syndrome

3. Etiological involvement of KCND1 variants in an X-linked neurodevelopmental disorder with variable expressivity

4. De novo missense variants in phosphatidylinositol kinase PIP5KIγ underlie a neurodevelopmental syndrome associated with altered phosphoinositide signaling

5. Comprehensive EHMT1 variants analysis broadens genotype-phenotype associations and molecular mechanisms in Kleefstra syndrome

6. Large-scale genomic investigation of pediatric cholestasis reveals a novel hepatorenal ciliopathy caused by PSKH1 mutations

7. Unveiling the crucial neuronal role of the proteasomal ATPase subunit genePSMC5in neurodevelopmental proteasomopathies

8. De novo missense variants in phosphatidylinositol kinase PIP5KIγ underlie a neurodevelopmental syndrome associated with altered phosphoinositide signaling

10. Correction: Aminoacyl-tRNA synthetase deficiencies in search of common themes

11. B56δ-related protein phosphatase 2A dysfunction identified in patients with intellectual disability

12. Correction to:De novo variants in SNAP25 cause an early-onset developmental and epileptic encephalopathy (Genetics in Medicine, (2021), 23, 4, (653-660), 10.1038/s41436-020-01020-w)

13. Truncating SRCAP variants outside the Floating-Harbor syndrome locus cause a distinct neurodevelopmental disorder with a specific DNA methylation signature

14. Characterization of SETD1A haploinsufficiency in humans and Drosophila defines a novel neurodevelopmental syndrome

15. Correction to: De novo variants in SNAP25 cause an early-onset developmental and epileptic encephalopathy

16. De novo variants in SNAP25 cause an early-onset developmental and epileptic encephalopathy

17. Cross-omics: Integrating genomics with metabolomics in clinical diagnostics

18. De novo coding variants in the AGO1 gene cause a neurodevelopmental disorder with intellectual disability

19. Disruption of RFX family transcription factors causes autism, attention deficit/hyperactivity disorder, intellectual disability, and dysregulated behavior

20. Expanding the Spectrum of BAF-Related Disorders : De Novo Variants in SMARCC2 Cause a Syndrome with Intellectual Disability and Developmental Delay

21. De Novo Heterozygous POLR2A Variants Cause a Neurodevelopmental Syndrome with Profound Infantile-Onset Hypotonia

22. Lysosomal Signaling Licenses Embryonic Stem Cell Differentiation via Inactivation of Tfe3

23. De Novo Heterozygous POLR2A Variants Cause a Neurodevelopmental Syndrome with Profound Infantile-Onset Hypotonia

24. Expanding the Spectrum of BAF-Related Disorders: De Novo Variants in SMARCC2 Cause a Syndrome with Intellectual Disability and Developmental Delay

25. Lysosomal Signaling Licenses Embryonic Stem Cell Differentiation via Inactivation of Tfe3

26. De Novo Heterozygous POLR2A Variants Cause a Neurodevelopmental Syndrome with Profound Infantile-Onset Hypotonia

27. De Novo Variants Disturbing the Transactivation Capacity of POU3F3 Cause a Characteristic Neurodevelopmental Disorder

28. Aminoacyl-tRNA synthetase deficiencies in search of common themes

29. Lysosomal Signaling Licenses Embryonic Stem Cell Differentiation via Inactivation of Tfe3

30. Expanding the Spectrum of BAF-Related Disorders: De Novo Variants in SMARCC2 Cause a Syndrome with Intellectual Disability and Developmental Delay

31. Bi-allelic mutations in TRAPPC2L result in a neurodevelopmental disorder and have an impact on RAB11 in fibroblasts

32. Bi-allelic mutations in TRAPPC2L result in a neurodevelopmental disorder and have an impact on RAB11 in fibroblasts

34. Rare GABRA3 variants are associated with epileptic seizures, encephalopathy and dysmorphic features

35. Mutations in N-acetylglucosamine (O-GlcNAc) transferase in patients with X-linked intellectual disability

36. De novo variants in SNAP25cause an early-onset developmental and epileptic encephalopathy

37. Germline mutations affecting the histone H4 core cause a developmental syndrome by altering DNA damage response and cell cycle control

38. MCM3AP in recessive Charcot-Marie-Tooth neuropathy and mild intellectual disability

39. De Novo Mutations in YWHAG Cause Early-Onset Epilepsy

40. WDR26 Haploinsufficiency Causes a Recognizable Syndrome of Intellectual Disability, Seizures, Abnormal Gait, and Distinctive Facial Features

41. Germline mutations affecting the histone H4 core cause a developmental syndrome by altering DNA damage response and cell cycle control

42. MCM3AP in recessive Charcot-Marie-Tooth neuropathy and mild intellectual disability

43. De Novo Mutations in YWHAG Cause Early-Onset Epilepsy

44. Mutations in N-acetylglucosamine (O-GlcNAc) transferase in patients with X-linked intellectual disability

45. WDR26 Haploinsufficiency Causes a Recognizable Syndrome of Intellectual Disability, Seizures, Abnormal Gait, and Distinctive Facial Features

46. Rare GABRA3 variants are associated with epileptic seizures, encephalopathy and dysmorphic features

47. De Novo Mutations in Protein Kinase Genes CAMK2A and CAMK2B Cause Intellectual Disability

48. De Novo Mutations in YWHAG Cause Early-Onset Epilepsy

49. WDR26 Haploinsufficiency Causes a Recognizable Syndrome of Intellectual Disability, Seizures, Abnormal Gait, and Distinctive Facial Features

50. Mutations in MDH2, Encoding a Krebs Cycle Enzyme, Cause Early-Onset Severe Encephalopathy

Catalog

Books, media, physical & digital resources